Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Estelle Bouron has worked on the following 22 EPO patent applications which have been published in the last five years:

EP11305874

Sustained release pharmaceutical oral solid dosage form of dronedarone or one of its pharmaceutically acceptable salts

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/50, A61K 31/343
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION REFUSED
EP11305875

Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts

IPC classification:
A61K 9/16, A61K 9/50, A61K 31/343
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION REFUSED
EP11305873

Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 9/50, A61K 31/343
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION REFUSED
EP13170242

Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation

IPC classification:
A61K 31/343, A61P 9/04
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
EXAMINATION IN PROGRESS
EP12711858

BENZOIC ACID SALT OF OTAMIXABAN

IPC classification:
A61K 31/44, A61P 9/00, C07D 213/16
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12710516

OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY

IPC classification:
A61K 9/00, A61K 31/4418, A61K 47/12, A61P 7/02
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
GRANT OF PATENT INTENDED
EP11754896

PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5

IPC classification:
A61K 31/343, A61P 9/00, C07C 39/04, C07C 251/16, C07D 307/80
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12733700

PHARMACEUTICAL COMPOSITION AND SOLID GALENIC FORM HAVING A HIGH DRONEDARONE CONTENT, AND METHOD FOR PREPARING SAME

IPC classification:
A61K 9/20, A61K 31/343, A61K 47/02, A61K 47/10, A61K 47/12, A61K 47/30, A61K 47/32, A61P 9/06
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
EXAMINATION REQUESTED
EP12731504

DRONEDARONE FOR THE PREVENTION OF ATRIAL FIBRILLATION

IPC classification:
A61K 31/343, A61P 9/04
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
GRANT OF PATENT INTENDED
EP11757603

DERIVATIVES OF N-[(1H-PYRAZOL-1-YL)ARYL]-1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE, THEIR PREPARATION AND THEIR USE AS P2Y12 ANTAGONISTS

IPC classification:
A61K 31/439, A61K 31/455, A61K 31/497, A61K 31/501, A61K 31/506, A61P 9/00, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 471/04, C07D 471/08, C07D 487/04, C07D 487/08
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12717364

PROCESS FOR SYNTHESIZING KETO-BENZOFURAN DERIVATIVES

IPC classification:
C07C 311/08, C07C 311/21, C07D 307/80, C07D 307/84
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12717365

METHOD FOR SYNTHESIZING KETOBENZOFURAN DERIVATIVES

IPC classification:
C07D 307/80, C07D 307/84
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11713080

USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER AMIODARONE DISCONTINUATION

IPC classification:
A61K 31/343, A61P 9/06
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306334

Derivatives of 1H-indole-3-carboxamide and their use as P2Y12 antagonists

IPC classification:
A61K 31/501, A61P 7/00, A61P 29/00, A61P 37/00, C07D 401/14, C07D 403/12
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION REFUSED
EP13305008

Compositions and methods using hdm2 antagonist and mek inhibitor

IPC classification:
A61K 31/404, A61K 31/44, A61K 31/455, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11712941

KETOBENZOFURAN DERIVATIVES, METHOD FOR SYNTHESISING SAME, AND INTERMEDIATES

IPC classification:
A61K 31/43, A61P 9/00, C07C 217/22, C07C 225/16, C07C 311/07, C07C 311/08, C07D 307/83, C07F 5/02
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13725136

DRONEDARONE FOR USE IN LEISHMANIASIS, FORMULATIONS AND ASSOCIATIONS FOR USE IN LEISHMANIASIS.

IPC classification:
A61K 31/343, A61P 33/02
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
GRANT OF PATENT INTENDED
EP13737259

USE OF VEGFR-3 INHIBITORS FOR TREATING HEPATOCELLULAR CARCINOMA

IPC classification:
A61K 31/4375, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi, S.A.
Agent:
Pascale A.M.P. Le Coupanec, Cabinet Nony
Agent:
Estelle Bouron, Sanofi
Status:
PATENT GRANTED
EP13758812

OTAMIXABAN FOR USE IN THE TREATMENT OF NON-ST ELEVATION ACUTE CORONARY SYNDROME IN PATIENTS PLANNED TO UNDERGO CORONARY ARTERY BYPASS GRAFTING

IPC classification:
A61K 31/4409, A61P 9/10
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
EXAMINATION IN PROGRESS
EP11754698

PROCESS FOR PREPARING AMINOBENZOYLBENZOFURAN DERIVATIVES

IPC classification:
C07D 307/80
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11796979

USE OF DRONEDARONE FOR THE PREPARATION OF A DRUG FOR USE IN THE MANAGEMENT OF THE RISK OF LIVER INJURY

IPC classification:
A61K 31/343, G01N 33/68
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP17155797

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR IN THE PREVENTION OF ATRIAL FIBRILLATION

IPC classification:
A61K 31/343, A61P 9/04
Applicant:
Sanofi, S.A.
Agent:
Estelle Bouron, Sanofi
Status:
The application has been published

Please Sign in to use this feature